Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOA2 Antikörper

Dieser Ziege Polyklonal Antikörper detektiert spezifisch APOA2 in WB, IP, IHC (p), EIA und IHC (fro). Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN116542
2.710,77 €
Zzgl. Versandkosten 20,00 € und MwSt
1 mg
Lieferung nach: Deutschland
Lieferung in 16 Werktagen

Kurzübersicht für APOA2 Antikörper (ABIN116542)

Target

Alle APOA2 Antikörper anzeigen
APOA2 (Apolipoprotein A-II (APOA2))

Reaktivität

  • 86
  • 41
  • 10
  • 6
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 73
  • 12
  • 8
  • 2
  • 2
  • 1
Ziege

Klonalität

  • 71
  • 27
Polyklonal

Konjugat

  • 46
  • 11
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser APOA2 Antikörper ist unkonjugiert

Applikation

  • 56
  • 29
  • 25
  • 20
  • 19
  • 17
  • 13
  • 13
  • 10
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Spezifität

    This product has been prepared by Immunoaffinity Chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities. Typically less than 1 % cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards. This antibody reacts with ApoLipoprotein A-II and has negligible cross-reactivity with Type A-I, B, C-I, C-II, C-III, E and J apoLipoproteins. Non-specific cross reaction of anti-apoLipoprotein antibodies with other Human serum proteins is negligible.

    Aufreinigung

    Immunoaffinity Chromatography.

    Immunogen

    ApoLipoprotein Type A-II was isolated from Human plasma by Density Gradient Centrifugation followed by HPLC purification.
  • Applikationshinweise

    This Apo AII antibody R1031P has been used for indirect trapping ELISA for quantitation ofantigen in serum using a standard curve, for Immunoprecipitation and Western blotting forhighly sensitive qualitative analysis. Recommended Dilutions: ELISA: 1/5,000-1/10,000. Immunoprecipitation: 1/100. Western blot: 1/5,000-1/10,000. Immunohistochemistry: 1: /50-1/200.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL (by UV absorbance at 280 nm)

    Buffer

    0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0 and 0.01 % Sodium Azide as preservative.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target

    APOA2 (Apolipoprotein A-II (APOA2))

    Andere Bezeichnung

    Apolipoprotein A II (Apo AII)

    Hintergrund

    Apolipoprotein A II is the second most abundant protein of the high density lipoprotein particles. The apolipoprotein A II gene consists of 4 exons and 3 introns. The four exons encode the 5' untranslated region, pre peptide, a short N terminal domain and a C terminal domain composed of a variable number of lipid binding amphipathic helices. Familial apolipoprotein A II deficiency may result from a splice junction alteration which blocks splicing of intron 3 from the primary transcript and result in the formation of a non functional mRNA.Synonyms: APOA2, Apo-AII, ApoA-II, Apolipoprotein A-II, Apolipoprotein A2

    Gen-ID

    336

    NCBI Accession

    NP_001634

    UniProt

    P02652

    Pathways

    Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Sie sind hier:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!